Literature DB >> 6972043

T cells respond preferentially to antigens that are similar to self H-2.

M J Bevan, T Hünig.   

Abstract

We have constructed bone marrow irradiation chimeras to investigate the influence of self antigens on the specificity of the T lymphocyte receptor repertoire. Bone marrow cells from (A X B)F1 mice heterozygous for the major histocompatibility genes were allowed to mature into T cells in irradiated parent A or parent B strains. More than 8 weeks after irradiation, when the lymphoid system had regenerated from the F1 stem cells, the degree of T cell reactivity to mutant major histocompatibility antigens, A', was assessed. It was found that T cells that had matured in the irradiated A mice, [F1 leads to A] chimeras, responded better to A' antigen than did T cells from the [F1 leads to B] chimeras. Because the mutant histocompatibility antigen A' is very similar in structure to A, differing only by one or a few residues, this suggests that the T cell repertoire in [F1 leads to parent] chimeras reacts preferentially with foreign antigens that are slight variants of the self antigens expressed on radiation-resistant cells--probably cells in the thymus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972043      PMCID: PMC319231          DOI: 10.1073/pnas.78.3.1843

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Estimates of the precursor frequency of cytotoxic T lymhocytes against antigens controlled by defined regions of the H-2 gene complex: comparison of the effect of H-2 differences due to intra-H-2 recombination vs mutation.

Authors:  M Pimsler; J Forman
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

2.  In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells.

Authors:  M J Bevan
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

3.  T-cell inhibition of humoral responsiveness. II. Theory on the role of restrictive recognition in immune regulation.

Authors:  M Cohn; R Epstein
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

Review 4.  Functional specificity of thymus- dependent lymphocytes.

Authors:  W E Paul; B Benacerraf
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

Review 5.  Cell-mediated immunity and the major histocompatibility complex.

Authors:  R E Langman
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

6.  Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice.

Authors:  H von Boehmer; W Haas; N K Jerne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 7.  Two different VH gene products make up the T-cell receptors.

Authors:  C A Janeway; H Wigzell; H Binz
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  Use of H-2 mutations to quantitate alloreactivity: Alloreactivity is strongest against H-2 antigens which are closet to self.

Authors:  M Pimsler; J Forman
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Human lymphocytes recognise mouse alloantigens.

Authors:  K F Lindahl; F H Bach
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  11 in total

1.  Positive selection of transgenic receptor-bearing thymocytes by Kb antigen is altered by Kb mutations that involve peptide binding.

Authors:  W C Sha; C A Nelson; R D Newberry; J K Pullen; L R Pease; J H Russell; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.

Authors:  J M Sheil; M J Bevan; L A Sherman
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 3.  Analysis of structure/function relationships among major histocompatibility complex class I antigens.

Authors:  J A Bluestone
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Clonal analysis of the specificity of alloreactive cells: "dominance" of E beta reactive clones.

Authors:  G Pobor; S Pettersson; A Coutinho
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Generation of the alloreactive T-cell repertoire: interaction of T-cell genotype and maturation environment.

Authors:  R E Gress; R J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Immunomodulatory effects of maternal atrazine exposure on male Balb/c mice.

Authors:  Alexander M Rowe; Kathleen M Brundage; Rosana Schafer; John B Barnett
Journal:  Toxicol Appl Pharmacol       Date:  2006-01-27       Impact factor: 4.219

7.  A single peptide-MHC complex positively selects a diverse and specific CD8 T cell repertoire.

Authors:  Baomei Wang; Tina M Primeau; Nancy Myers; Henry W Rohrs; Michael L Gross; Lonnie Lybarger; Ted H Hansen; Janet M Connolly
Journal:  Science       Date:  2009-11-06       Impact factor: 47.728

8.  Effect on IgE production of transplanted cultured thymic fragments.

Authors:  M Nishikawa; R Hong
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

9.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis.

Authors:  T R Hünig; M J Bevan
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

Review 10.  Recognition of self and altered self by T cells in autoimmunity and allergy.

Authors:  Lei Yin; Shaodong Dai; Gina Clayton; Wei Gao; Yang Wang; John Kappler; Philippa Marrack
Journal:  Protein Cell       Date:  2013-01-11       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.